Abstract:Vascular smooth muscle cell (SMC) growth plays an important role in atherosclerosis, restenosis and venous bypass graft disease. With systemic drug administration no effective therapy for restenosis and venous bypass graft disease is available. This could be due to low local concentrations of the drugs at the target site. A directed delivery of drugs to tissues with a sustained release system during percutaneous transluminal coronary angioplasty (PTCA) or during bypass surgery could provide high concentrations of drugs at the target site and avoid systemic side effects. In the present study heparin was encapsulated by spray-drying into biodegradable poly(D, L-lactic-co-glycolic acid) (PLGA) to obtain a system for prolonged drug release. SMC were cultured from saphenous vein explants obtained from patients undergoing coronary bypass surgery. Cell proliferation was measured by [(3)H]thymidine incorporation. Heparin release from PLGA 50:50 microspheres in an isoosmolar PBS buffer (pH=7.4) showed a triphasic profile with an initial burst (completed after 24 h), a dormant period and a final stage with increased release rate, which lasted about 10-14 days. Cell proliferation as measured by [(3)H]thymidine incorporation was markedly stimulated by platelet-derived growth factor-BB (PDGF-BB) (5 ng/ml) or serum (5%). Proliferation of SMC was equally reduced (50%; P<0.05; n=9-11) by native heparin or heparin released from PLGA microspheres, while PLGA microspheres without heparin loading had no effect on [(3)H]thymidine incorporation in human SMC. Similar results were also obtained when SMC were stimulated with 5% serum instead of PDGF-BB (50%; P<0.05; n=6). Thus, heparin encapsulated into PLGA microspheres was released over a prolonged period of time and thereby effectively reduced human SMC proliferation stimulated either with PDGF or serum. Biodegradable PLGA microspheres may also be used to encapsulate other antiproliferative agents and provide a new approach for local drug delivery after PTCA. This may help to prevent restenosis after PTCA or to reduce graft disease after coronary bypass graft surgery.

Sustained Release of Low Molecular Weight Heparin from PLGA Microspheres Prepared by a Solid-in-oil-in-water Emulsion Method.

A One-Step Modified Method to Reduce the Burst Initial Release from Plga Microspheres

Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Preparation and Characterization of Hcg-Loaded Polylactide or Poly(lactide-Co-glycolide) Microspheres Using a Modified Water-in-oil-in-water (w/o/w) Emulsion Solvent Evaporation Technique

Facile Preparation of PLGA Microspheres with Diverse Internal Structures by Modified Double‐emulsion Method for Controlled Release

Novel Preparation Method for Sustained-Release Plga Microspheres Using Water-In-Oil-In-Hydrophilic-Oil-In-Water Emulsion

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

A method to prepare PLGA sustained-release microspheres

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Development of Composite PLGA Microspheres Containing Exenatide-Encapsulated Lecithin Nanoparticles for Sustained Drug Release.

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

A Novel Preparation Method for Microspheres by Glycerol Modified Solid‐in‐oil‐in‐water Multi‐emulsion

An In Situ Gel-Forming Heparin-Conjugated PLGA-PEG-PLGA Copolymer

Controlled Release of Lysozyme-Loaded Microspheres in Hydrogel Implants

PLGA Microspheres Prepared Via Aqueous-aqueous Emulsification for Pulsed Drug Delivery

Anhydrous Reverse Micelle Lecithin Nanoparticles/plga Composite Microspheres for Long-Term Protein Delivery with Reduced Initial Burst

Preparation, Characterization and in Vitro Evaluation of IVM Loaded Poly(lactic-Co-Glycolic Acid) (PLGA) Microspheres

Release mechanisms of bovine serum albumin loaded–PLGA microspheres prepared by ultra-fine particle processing system

Preparation of BSA-PLG Microspheres by S/W/O/W Method